ADLM 2025 Global Webinar: Chronic Kidney Disease & Cystatin C

Originally broadcast on June 24, 2025

Chronic kidney disease (CKD) continues to pose a significant global health challenge, with early detection and accurate diagnostics playing a crucial role in improving patient outcomes. Sponsored by QuidelOrtho, this ADLM-accredited webinar—now available on demand—features Dr. Amy Pyle-Eilola, PhD, DABCC, FADLM, Director of Clinical Chemistry at Nationwide Children’s Hospital, presenting expert insights on the clinical and operational value of cystatin C testing.

The session covers:

• Key updates from the 2024 KDIGO CKD guidelines
• When and how to use cystatin C to improve GFR estimation
• Practical strategies for implementing cystatin C in clinical laboratories, including barriers and real-world solutions

Cystatin C offers enhanced accuracy in estimating glomerular filtration rate across diverse patient populations, helping laboratories align diagnostic strategies with the most current international guidelines.*

This webinar is ideal for clinical laboratory professionals, pathologists, and healthcare leaders seeking to strengthen their kidney health testing protocols.

ACCENT^® Continuing Education Credit is available through ADLM. The deadline for obtaining credit is June 30, 2026.

Learn more about how our Diazyme cystatin C MicroTip Partnership Assay (MPA) can help streamline CKD testing and enable better clinical decision-making.

*KDIGO Cystatin C Working Group. (2022). KDIGO 2022 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 102(1), S1–S127. https://doi.org/10.1016/j.kint.2022.04.003

By clicking this link, you are leaving QuidelOrtho’s website and entering a third-party site not controlled by QuidelOrtho. We are not responsible for the content, security, or privacy practices of external sites, and do not endorse them. Any information you provide will be governed by the third party’s terms and privacy policy. To the fullest extent permitted by law, QuidelOrtho disclaims all liability for your use of third-party sites. By proceeding, you accept these terms and assume all associated risks.